Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gentamicin-resistant infections in peritoneal dialysis patients using topical gentamicin exit-site prophylaxis: a report of two cases.

× No keyword cloud information.

16 in total

1. Resistance to mupirocin: no indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients.

Authors: S I Vas; J Conly; J M Bargman; D G Oreopoulos
Journal: Perit Dial Int Date: 1999 Jul-Aug Impact factor: 1.756

2. Microbiology and outcomes of peritonitis in North America.

Authors: S Mujais
Journal: Kidney Int Suppl Date: 2006-11 Impact factor: 10.545

3. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis.

Authors: Daniel L Landry; Gregory L Braden; Stephen L Gobeille; Sarah D Haessler; Chirag K Vaidya; Stephen J Sweet
Journal: Clin J Am Soc Nephrol Date: 2010-07-01 Impact factor: 8.237

4. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection.

Authors: R Annigeri; J Conly; S Vas; H Dedier; K P Prakashan; J M Bargman; V Jassal; D Oreopoulos
Journal: Perit Dial Int Date: 2001 Nov-Dec Impact factor: 1.756

5. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.

Authors: Christopher Thiam-Seong Lim; Kok-Seng Wong; Marjorie Wai-Yin Foo
Journal: Nephrol Dial Transplant Date: 2005-04-26 Impact factor: 5.992

6. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.

Authors: Judith Bernardini; Filitsa Bender; Tracey Florio; James Sloand; Linda Palmmontalbano; Linda Fried; Beth Piraino
Journal: J Am Soc Nephrol Date: 2004-12-29 Impact factor: 10.121

7. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group.

Authors:
Journal: J Am Soc Nephrol Date: 1996-11 Impact factor: 10.121

8. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.

Authors: Thierry Lobbedez; Michael Gardam; Helen Dedier; Dorothy Burdzy; Maggie Chu; Sharon Izatt; Joanne M Bargman; Sarbjit V Jassal; Stephen Vas; James Brunton; Dimitrios G Oreopoulos
Journal: Nephrol Dial Transplant Date: 2004-10-05 Impact factor: 5.992

9. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.

Authors: E Thodis; S Bhaskaran; P Pasadakis; J M Bargman; S I Vas; D G Oreopoulos
Journal: Perit Dial Int Date: 1998 May-Jun Impact factor: 1.756

10. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD).

Authors: S J Davies; C S Ogg; J S Cameron; S Poston; W C Noble
Journal: Perit Dial Int Date: 1989 Impact factor: 1.756

3 in total

Gentamicin-resistant infections in peritoneal dialysis patients using topical gentamicin exit-site prophylaxis: a report of two cases.